Form 4: KALA BIO CFO Sells Shares to Cover Tax Obligations

KALA BIO's Chief Financial Officer, Mary Reumuth, sold 3,631 shares of common stock on June 24, 2025, at a weighted average price of $4.01 per share, to satisfy tax withholding obligations.

Summary

• Mary Reumuth, Chief Financial Officer of KALA BIO, Inc. (KALA), reported a sale of common stock.
• The transaction involved the disposition of 3,631 shares of KALA common stock on June 24, 2025.
• The shares were sold at a weighted average price of $4.01 per share, with individual transaction prices ranging from $3.87 to $4.12.
• This sale was executed pursuant to a Rule 10b5-1 trading plan, which was adopted by Ms. Reumuth on November 9, 2020.
• The primary purpose of the sale was to cover tax withholding obligations associated with the vesting and settlement of restricted stock units (RSUs) that were granted to Ms. Reumuth on June 22, 2023.
• Following this transaction, Ms. Reumuth beneficially owns 62,100 shares of KALA BIO common stock, which includes 28,906 unvested RSUs.

Sentiment

Score: 5

Explanation: The transaction is a routine sale by an insider to cover tax withholding obligations associated with the vesting of restricted stock units, executed under a pre-arranged 10b5-1 trading plan. This type of transaction is generally considered neutral as it does not reflect a discretionary investment decision based on new information about the company's performance or outlook.

Positives

• The sale was conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a structured and non-discretionary transaction rather than a discretionary sale based on new information.

Negatives

• An insider sale, even for tax purposes, results in a reduction of the insider's direct equity stake in the company.

Risks

• The document itself does not introduce new risks but reports a routine insider transaction.

Future Outlook

NA

Management Comments

• The sale was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 9, 2020, to cover tax withholding obligations in connection with the vesting and settlement of the Reporting Person's restricted stock units ('RSUs') granted on June 22, 2023.

Industry Context

This Form 4 filing reports a routine insider transaction and does not provide broader industry context or trends.

Stakeholder Impact

• Shareholders: The sale represents a minor reduction in the insider's direct equity stake, but its pre-planned nature for tax purposes mitigates concerns about discretionary selling.
• Employees, Customers, Suppliers, Creditors: No direct impact on these stakeholders is indicated by this filing.

Next Steps

• NA

Key Dates

Recommendation

Keywords

KALA BIO, KALA, Mary Reumuth, CFO, Form 4, Insider Trading, Stock Sale, 10b5-1 Plan, Restricted Stock Units, RSU, Tax Withholding